Atlas Trials

A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects

Clinical trial NCT04703868 · COMPLETED

Trial details

NCT number
NCT04703868
Sponsor
Yungjin Pharm. Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease
Start date
2021-01-13
Primary completion
2021-06-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.